Global Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Mirum Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Cresco Labs

Market Cap: CA$724.0m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Pfizer

Market Cap: ₹233.2b

Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.

NATCO Pharma

Market Cap: ₹164.2b

A pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.

SNDL

Market Cap: US$525.3m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.

Amylyx Pharmaceuticals

Market Cap: US$1.3b

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Axsome Therapeutics

Market Cap: US$7.4b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

ADMA Biologics

Market Cap: US$4.5b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Daiichi Sankyo Company

Market Cap: JP¥6.1t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Karyopharm Therapeutics

Market Cap: US$108.6m

A commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States.

Eton Pharmaceuticals

Market Cap: US$429.6m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Precigen

Market Cap: US$1.5b

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Nuvation Bio

Market Cap: US$3.1b

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

Century Therapeutics

Market Cap: US$66.7m

A clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.

Phibro Animal Health

Market Cap: US$1.6b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Agilent Technologies

Market Cap: US$38.8b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Neurocrine Biosciences

Market Cap: US$14.1b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Botanix Pharmaceuticals

Market Cap: AU$236.5m

Operates as a commercial dermatology company in Australia and the United States.

ABIVAX Société Anonyme

Market Cap: €7.8b

A clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

Sana Biotechnology

Market Cap: US$1.2b

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

Artiva Biotherapeutics

Market Cap: US$114.1m

A clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.

Tango Therapeutics

Market Cap: US$1.1b

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Rezolute

Market Cap: US$171.5m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

Roivant Sciences

Market Cap: US$15.2b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Merck

Market Cap: Rp1.5t

Engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally.

BICO Group

Market Cap: SEK 1.3b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Grifols

Market Cap: €6.6b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Neumora Therapeutics

Market Cap: US$292.3m

A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.

Organigram Global

Market Cap: CA$379.4m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Absci

Market Cap: US$508.3m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

ImmunityBio

Market Cap: US$2.1b

A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.

Haleon

Market Cap: UK£33.3b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Protagonist Therapeutics

Market Cap: US$5.4b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Perrigo

Market Cap: US$1.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Ginkgo Bioworks Holdings

Market Cap: US$468.3m

Develops a platform for cell programming in the United States.

Theriva Biologics

Market Cap: US$5.9m

A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.